RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)

Inclusion Criteria: PATIENT: * Age between 20 and 85 years * Signed informed consent * Acceptance of late angiographic control (6-9 months) * Angina and / or objective evidence of ischemia LESION: * In-Stent restenosis (\> 50% visual) any drug-eluting stent * Knowledge of prior stent location Exclusion Criteria: PATIENT: * Inclusion in another clinical research protocol * Women of childbearing age * Severe associated systemic disease (including renal or liver failure) * Severe depression of left ventricular ejection fraction (LVEF \<25%) * Disease that affects life expectancy * Recent myocardial infarction ( \<7 days) * Time of implantation of the previous DES \<1 month * Severe difficulties expected for late angiographic study LESION: * Angiographic failure during implementation of initial stent(residual stenosis\> 50%) * Image of large thrombus in-stent (\> vessel diameter) * Tortuosity or Ca + + with very severe difficulties during prior stent deployment * Vessel diameter \<2 mm (visual estimate) * Restenosis only "outside" the stent (The edge of the stent is not affected) * Completely occlusive restenosis (100%, TIMI 0) * Very diffuse restenosis (\> 30 mm length)